Northway Biotech
Biologics CDMO located in Waltham, MA, and Vilnius, Lithuania
Biologics CDMO located in Waltham, MA, and Vilnius, Lithuania
Analysis of Northway Biotech
Northway Biotech is a Contract Development and Manufacturing Organization (CDMO) with a stronghold in the biopharmaceutical value chain. Established in 2004, it operates from Waltham, MA, USAVilnius, Lithuania, EU. The company's expertise lies in drug substance and drug product development, as well as GMP compliant manufacturing, covering the whole spectrum from gene to drug manufacturing in microbial and mammalian expression systems.
What sets Northway Biotech apart is its agility and adaptability in responding to unforeseen project changes, aligning timelines, and offering additional capacities to meet evolving customer needs. The company is committed to delivering top-notch contract development and manufacturing services with extensive flexibility and responsiveness, underpinned by a strong foundation in science and technology innovation.
The range of end-to-end services offered by Northway Biotech encompasses Cell Line (Mammalian & Microbial) Development, Analytical Methods Development, Formulation Development, Upstream & Downstream Process Development (USP & DSP), cGMP Manufacturing of Biologics & Biosimilars (Drug Substance, Drug Product), cGMP Master and Working Cell Bank Manufacturing, cGMP pDNA Manufacturing, Fill & Finish (F&F), and Quality Assurance, Quality Control, and Regulatory CMC Support.
Northway Biotech is a prominent player in the Biotechnology industry and offers a compelling investment opportunity for venture capitalists seeking to support the advancement of biopharmaceutical solutions.
There is no investment information
No recent news or press coverage available for Northway Biotech.
We care about your data, and we'd love to use cookies make your experience better.